Renowned Neurosurgeon Elevates Patient Care with Expertise in Neuro-Oncology and Innovative Surgical Techniques St. Elizabeth’s Medical Center and Steward Medical Group are proud to announce that Ekkehard Kasper, MD, an internationally recognized neurosurgeon and expert in neuro-oncology, has joined their medical staff as Regional Chief
Xylonix, a fast-growing Singapore-based pharmaceutical company specializing in innovative oncology and immunology products, is proud to announce a strategic partnership with Genecast, a pioneering cancer diagnostics company from Korea. This collaboration aims to advance the field of early precision cancer diagnostics and cancer metastasis research, leveraging
The Key Dry Eye Disease Companies in the market include – Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye
Covington, Kentucky, Dec. 21, 2022 – Gravity Diagnostics, a CAP-accredited, CLIA-certified laboratory licensed in all 50 states, has officially welcomed Erica Adams as their Director of Compliance. Ms. Adams will oversee the compliance program across the company, deciphering current and proposed legislation, and implementing structures
ZenFlex ONE Features a Counter-Clockwise Flute for Doctors Using Reciprocating Motion When Shaping BREA, California, November 23, 2022 – Kerr Dental announces the launch of its novel ZenFlex ONE reciprocating file featuring a counter-clockwise flute. The new ZenFlex ONE file, alongside its matching Gutta Percha
PARIS, FRANCE and TAMPA, FL July 11, 2022 – SafeHeal, a leading innovator in the field of digestive surgery and developer of the Colovac device, announced today the appointment of Chris Richardson as Chief Executive Officer (CEO), who assumes responsibilities immediately. Richardson has over 30 years of
Contract Manufacturing Organization first in Europe to License DehydraTECH Lexaria will receive milestone fees and royalty payments from product sales Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce the awarding of a European
